TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.
TippingPoint Biosciences has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in March 2026.
TippingPoint Biosciences's investors include Sazze Partners, Mission BioCapital, SOSV, SOSV SF & NY (Fka IndieBio), Freeflow Ventures.
TippingPoint Biosciences is headquartered in San Francisco, United States.
TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.
TippingPoint Biosciences is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TippingPoint Biosciences — Funding & Investors." VCBacked, March 31, 2026, https://www.vcbacked.co/company/tippingpoint-biosciences. Accessed October 11, 2026.
VCBacked. (2026). TippingPoint Biosciences — Funding & Investors. Retrieved October 11, 2026, from https://www.vcbacked.co/company/tippingpoint-biosciences
{{cite web |title=TippingPoint Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/tippingpoint-biosciences |website=VCBacked |access-date=October 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated